0001104659-23-001103.txt : 20230104
0001104659-23-001103.hdr.sgml : 20230104
20230104212822
ACCESSION NUMBER: 0001104659-23-001103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD
CENTRAL INDEX KEY: 0000941841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 23509561
MAIL ADDRESS:
STREET 1: 375 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10152
FORMER NAME:
FORMER CONFORMED NAME: ROSENWALD LINDSAY MD
DATE OF NAME CHANGE: 19950316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
tm231728-9_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-01
0
0001429260
Fortress Biotech, Inc.
FBIO
0000941841
ROSENWALD LINDSAY A MD
C/O FORTRESS BIOTECH, INC.
1111 KANE CONCOURSE SUITE 301
BAY HARBOR ISLANDS
FL
33154
1
1
1
0
President, CEO & Chairman
COMMON STOCK, PAR VALUE $0.001
2022-06-01
4
A
0
4264
0.73
A
11734588
D
COMMON STOCK, PAR VALUE $0.001
2023-01-01
4
A
0
1219294
0.00
A
12953882
D
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
The Reporting Person was granted 1,219,294 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2023.
/s/ Samuel Berry, Attorney-in-Fact
2023-01-04